The challenges of assessing fidelity to physician-driven HIV prevention interventions: lessons learned implementing Partnership for Health in a Los Angeles HIV clinic

AIDS and Behavior
Ellen F IversonJan B King

Abstract

Documenting fidelity to HIV prevention interventions is critical to ensure consistency in intervention implementation and necessary for measuring intervention exposure and, ultimately, outcomes. Significant variation from prescribed protocols or inconsistent implementation can jeopardize the integrity of evaluation research and render outcomes uninterpretable. There is increasing support for HIV prevention models targeting seropositive individuals designed to be delivered by physicians during clinic visits. Assessing fidelity to physician-delivered interventions that occur during clinical exams present unique challenges. This paper presents findings from various data sources designed to track intervention fidelity and exposure to the Partnership for Health intervention, a physician-delivered HIV prevention intervention implemented in an urban community HIV clinic. We present findings from chart abstraction data, patient surveys and exit interviews, and provider qualitative interviews. Lessons learned and recommendations for maximizing the accuracy and validity of fidelity assessment in future evaluations of HIV prevention interventions in primary care settings are considered.

References

Jan 1, 1991·Journal of General Internal Medicine·J K OckeneK Kalan
May 1, 1997·Preventive Medicine·J CornuzB Burnand
Mar 14, 1998·Annals of Internal Medicine·R M EpsteinH B Beckman
Apr 25, 2001·Journal of General Internal Medicine·R M EpsteinP Franks
Jul 10, 2001·American Journal of Public Health·R S JanssenK M De Cock
Jul 18, 2001·American Journal of Preventive Medicine·S C KalichmanJ Graham
Sep 10, 2003·American Journal of Psychotherapy·Mallory O Johnson, Robert H Remien
Dec 18, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Joseph P McGowanPaul J Weidle
Jun 29, 2004·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Stephen F MorinMargaret A Chesney
Sep 10, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Judith A AbergUNKNOWN HIV Medicine Association of the Infectious Diseases Society of America
Dec 13, 2005·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Jeffrey D FisherGerald H Friedland
Sep 22, 2006·AIDS Education and Prevention : Official Publication of the International Society for AIDS Education·Charles CollinsMyriam Hamdallah
Dec 7, 2006·Palliative Medicine·Celine M KoropchakJames A Tulsky
Mar 14, 2007·Archives of Internal Medicine·Sheri A KeitzJames A Tulsky
Feb 2, 2008·Arthritis and Rheumatism·Betsy SleathAshley Beard

❮ Previous
Next ❯

Citations

Jun 29, 2010·The Journal of Primary Prevention·Seth C KalichmanGiorgio Diberto
Mar 22, 2014·Translational Behavioral Medicine·Joseph A CataniaVirginia R McKay
Jan 7, 2014·Implementation Science : IS·Shayna D Cunningham, Josefina J Card
Jul 3, 2013·Journal of Substance Abuse Treatment·Mary Hatch-MailletteDonald A Calsyn
Jan 15, 2015·Translational Behavioral Medicine·M Margaret DolciniElizabeth M Ozer
Sep 4, 2008·Current Infectious Disease Reports·Albert M Anderson, Jeffrey L Lennox
Oct 24, 2008·Current Infectious Disease Reports·Brenna L Anderson, Susan Cu-Uvin
Jan 13, 2009·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Brenna L Anderson, Susan Cu-Uvin
Nov 1, 2014·Journal of Community Psychology·Virginia R MckayJoseph A Catania

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

AIDS Education and Prevention : Official Publication of the International Society for AIDS Education
Mark ThrunCarol E Golin
Journal of Acquired Immune Deficiency Syndromes : JAIDS
Elizabeth A TorroneThomas A Peterman
© 2022 Meta ULC. All rights reserved